Key facts
- This page summarizes Christopher Klein's Form 4 filing for Osmotica Pharmaceuticals plc.
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 20 May 2021, 16:06.
Christopher Klein - 18 May 2021 Form 4 Insider Report for Osmotica Pharmaceuticals plc
- Reporting relationship
- General Counsel & Secretary
- Issuer ticker
- N/A
- Reported as of
- 18 May 2021
- Net transaction value
- -$20,177
- SEC form
- 4
- Accepted by SEC
- 20 May 2021, 16:06:22 UTC
- Next SEC filing
- 08 Nov 2021
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ Christopher Klein
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Christopher Klein filed Form 4 for Osmotica Pharmaceuticals plc on 20 May 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: -$20,177.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RVLP
transaction
Ordinary Shares
Tax liability
- Transaction value
- $20,177
- Shares
- -6,467
- Change %
- -3%
- Price
- $3.12*
- Shares after
- 211,362
- Date
- 18 May 2021
- Ownership
- Direct
* marks a reported price that did not pass the local price check.